Dr. Madeline Jones Cancian, MD

Dr. Cancian practices at Brown Urology, Inc DBA Collyer Street Operatory - HOPD in Providence, Rhode Island.

Dr. Cancian's NPI, 1942647276, was assigned on May 28, 2013. Dr. Cancian holds Rhode Island license MD16744.

Dr. Cancian's primary practice is Brown Urology, Inc DBA Collyer Street Operatory - HOPD, at 195 Collyer St, Providence, RI 02904.

Dr. Cancian's primary practice is Brown Urology, Inc DBA Collyer Street Operatory - HOPD in Providence, Rhode Island. Dr. Cancian is also affiliated with The Miriam Hospital. The medical group on file is Brown Health Medical Group. Dmand AI also links Dr. Cancian to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Cancian's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cancian practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Cancian's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Cancian's licenses on file in 2 states: Rhode Island and Georgia.

CMS data shows 1,023 Medicare services from Dr. Cancian across 12 procedure codes in 2024, for 336 Medicare patients. Medicare paid $64,860 for them.

CMS counts 336 Medicare patients who saw Dr. Cancian in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cancian's median patient age at 68, with 35% women.

In 2024, Dr. Cancian wrote 841 Medicare Part D claims for 271 patients. 82% of them were for generic drugs. CMS names the drug for 746 of them, across 17 drugs with 11 or more claims each, at $110,136 in total drug cost. In 2023, CMS named 643 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Cancian for performance year 2024, reported individually. Dr. Cancian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cancian as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Cancian, published from 2016 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Urologic Surgical Procedures and Fournier Gangrene. Dr. Cancian has published most often in Urology. Dr. Cancian's most frequent co-authors are Martus Zheng Quan Gn, Lindsey Marie Hartsell, MD and Amir Farah, MD.

CMS Open Payments shows 21 general payments to Dr. Cancian from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 77% of the total. Boston Scientific Corporation paid the most, $271.